Dyne Therapeutics, Inc.
DYN
$25.70
-$0.26-1.00%
NASDAQ
| 06/30/2026 | 03/31/2026 | 12/31/2025 | 09/30/2025 | 06/30/2025 | |
|---|---|---|---|---|---|
| Net Income | -178.56M | -120.85M | -111.96M | -108.04M | -110.86M |
| Total Depreciation and Amortization | 560.00K | 550.00K | 521.00K | 523.00K | 503.00K |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | 14.91M | 13.01M | 10.91M | 10.87M | 10.01M |
| Change in Net Operating Assets | 32.80M | -37.62M | -11.31M | 5.87M | 5.64M |
| Cash from Operations | -130.29M | -144.92M | -111.83M | -90.78M | -94.70M |
| Capital Expenditure | -1.51M | -221.00K | -484.00K | -19.19M | -60.00K |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -3.28M | -2.17M | 1.47M | -18.78M | 6.83M |
| Cash from Investing | -4.80M | -2.39M | 982.00K | -37.97M | 6.77M |
| Total Debt Issued | 60.70M | 6.79M | 49.45M | 0.00 | 98.80M |
| Total Debt Repaid | -3.33M | -579.00K | -- | -- | -- |
| Issuance of Common Stock | 737.00K | 1.31M | 381.52M | 217.88M | 1.97M |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | 0.00 | -454.00K | -9.00K | -549.00K | -- |
| Cash from Financing | 58.11M | 7.06M | 430.97M | 217.33M | 100.77M |
| Foreign Exchange rate Adjustments | -- | -- | -- | -- | -- |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | -76.97M | -140.25M | 320.12M | 88.58M | 12.85M |